Framingham Risk Score Calculator

The Framingham Risk Score was developed from the Framingham Heart Study, a landmark longitudinal study of residents of Framingham, Massachusetts that began in 1948 and has now followed three generations. By tracking which participants developed coronary heart disease and correlating outcomes with baseline risk factors, researchers were able to build a predictive model that assigns sex-specific, age-adjusted points to six key variables: age, total cholesterol, HDL cholesterol, systolic blood pressure (with a separate tier for treated hypertension), smoking status, and diabetes.

The core formula is Total Points = Age pts + Cholesterol pts + HDL pts + BP pts + Smoking pts + Diabetes pts. Each component contributes a different weight depending on your sex and your value within that category. For example, a man aged 60 with total cholesterol of 250 earns more points than a woman of the same age and cholesterol because the Framingham data showed cholesterol was a stronger independent predictor in men at that age. The total point score maps to a 10-year percentage risk via validated lookup tables. Heart age is calculated separately: the calculator searches for the age at which an optimally healthy person of your sex — non-smoker, no diabetes, ideal cholesterol and blood pressure — would have the same total points as you, revealing how much your risk factors have biologically aged your cardiovascular system beyond your calendar years.

Not all risk factors contribute equally to the Framingham point total, and understanding which ones are most impactful guides intervention priorities. Smoking is one of the single largest individual contributors — active smoking adds four to nine points depending on age and sex, corresponding to a two-to-three-fold increase in coronary event risk. The good news is that cessation reduces this contribution sharply: ex-smokers who have not smoked for more than a year are scored as non-smokers, and their overall CVD risk drops by approximately 50% within 12 months.

Blood pressure control is the second most modifiable high-impact variable. Reducing systolic blood pressure from 160 mmHg to below 120 mmHg eliminates two to four points from the total depending on whether you are on antihypertensive medication. HDL cholesterol also moves the score significantly in both directions: an HDL below 35 mg/dL adds points; an HDL above 60 mg/dL subtracts points, functioning as a protective factor. Total cholesterol above 280 mg/dL adds the maximum cholesterol points regardless of further elevation, so the marginal benefit of each additional cholesterol reduction is largest in the 200–280 mg/dL range. Age and diabetes are not modifiable, but they illustrate why early intervention on the controllable factors matters: each decade of untreated elevated cholesterol or blood pressure allows the age-related point accumulation to compound without the protective offset of well-managed modifiable factors.

The Framingham Risk Score is a powerful tool but carries several well-documented limitations. It was derived primarily from a White, middle-class Massachusetts population and tends to overestimate risk in some European and Asian ethnic groups, and to underestimate risk in South Asian populations. The 2013 AHA/ACC Pooled Cohort Equations (PCE) attempted to address this by including African American populations in the derivation cohort, though the PCE's own calibration has been questioned in other ethnic groups.

The model captures only six variables and cannot incorporate family history of early-onset cardiovascular disease, inflammatory markers (high-sensitivity CRP), coronary artery calcium score, or imaging-detected subclinical atherosclerosis — all of which add independent predictive power in research settings. Individuals with established cardiovascular disease (prior heart attack, stent, bypass surgery) are already in the highest risk tier regardless of their Framingham score and should be managed accordingly. The score also cannot predict individual outcomes — it estimates population-level probability, so a score of 15% does not mean a 15% chance for you specifically; it means that among 100 people identical to you in all six inputs, approximately 15 would experience a coronary event in the next decade. For borderline-risk patients (7.5–20%), additional testing like a coronary artery calcium (CAC) scan is often recommended to reclassify risk and inform statin decisions more precisely.